Screening of signal transducing molecules by using transient expression
Screening of signal transducing molecules by using transient expression
批准号:
10557038
负责人:
YOSHIMURA Akihiko
金额:
$7.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
为了寻找对细胞增殖或分化起重要作用的酪氨酸激酶的新底物,我们建立了以活性c-kit为诱饵的双杂交筛选方法。我们克隆了含有SH2结构域和PH结构域的新的接头分子APS和STAP-1。RT-POR分析显示STAP-1仅在表达c-kit的骨髓细胞组分表达,CD34-SCA-1+c-Kit+LIN-造血干细胞富集组表达最强。小鼠髓系细胞株M1高表达STAP-1。但在白血病抑制因子诱导M1细胞向单核细胞分化时,STAP-1的表达被强烈抑制,提示STAP-1与未分化的细胞类型有关。在293细胞中,STAP-1被激活的c-kit蛋白酪氨酸磷酸化。体外结合实验表明,STAP-1SH2结构域与c-kit和STAT5等多种酪氨酸磷酸化蛋白相互作用。这些结果表明STAP-1具有…的功能在造血干细胞中c-kit下游有更多的daptor分子。此外,我们最近克隆了一种新的c-kit或其他酪氨酸激酶底物。这个基因,我们称之为WARS,不包含任何SH2或PH结构域,但有一个新的结构域与果蝇中Ras-MAP激酶的负调节基因相关。我们将试图发现该基因在癌症发生发展中的作用。我们克隆了一个新的SH2蛋白Jab,它与JAK2的激活域相结合。Jab与JAK酪氨酸激酶相互作用并抑制其活性。通过SH2结构域,Jab与JAK激酶激活环中的磷酸酪氨酸结合并抑制其催化活性。我们已经证明,干扰素-γ强烈地诱导了JAB。我们证明,JAB缺陷小鼠在围产期死亡,淋巴发育改变,包括体内激活的T细胞的产生。这种致命性在RAG2或干扰素-γ上被消除。背景不足。根据这一结果,我们认为Jab在干扰素-γ的负反馈调节中起着重要作用。较少
英文摘要
To identify the novel substrate of tyrosine kinases which is important for proliferation or differentiation, we developed a two-hybrid screening using active c-kit as bait. We cloned new adaptor molecules, APS and STAP-1 which contain SH2 domain and PH domain. RT-POR analysis revealed that STAP-1 expression is restricted in bone marrow cell fraction expressing c-kit, and the highest expression was observed in CD34-Sca-1+c-Kit+Lin- hematopoietic stem cell enriched fraction. Murine myeloid cell line, M1 expressed high level of STAP-1. However, the expression was strongly repressed in response to leukemia inhibitory factor which induced monocytic differentiation of M1 cells, suggesting that STAP-1 is associated with undifferentiated cell type. In 293 cells, STAP-1 was tyrosine phosphorylated by activated c-kit. In vitro binding assay suggested that STAP-1 SH2 domain interacted with several tyrosine phosphorylated protein including c-kit and STAT5. These suggest that STAP-1 function as a a … More daptor molecule downstream of c-kit in hematopoietic stem cells.Furthermore, we recently cloned a novel substrate of c-kit or other tyrosine kinases. This gene, we call WARS, does not contain any SH2 or PH domain but has a novel domain related to a gene that is a negative regulator of Ras-MAP kinase in Drosophila. We will try to find the function of this gene in development of cancer.We cloned a novel SH2 protein JAB, that binds to the kinase domain of JAK2. JAB interacts with and inhibits JAK tyrosine kinases. Through the SH2 domain, JAB binds to a phosphotyrosine in the activation loop of the JAK kinases and suppresses their catalytic activity. We have shown that JAB is strongly induced by interferon-γ. We demonstrate that JAB deficient mice die perinatally with altered lymphoid development including the generation of activated T cells in vivo. The lethality is eliminated on a Rag2 or interferon-γ. Deficient background . Based on the results, we propose that JAB plays an essential role in negative feedback regulation of interferon-γ. Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sasaki A, et al: "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain."Genes to Cells. 4,6. 339-351 (1999)
Sasaki A 等人:“细胞因子诱导型 SH2 蛋白 3 (CIS3/SOCS3) 通过 N 端激酶抑制区以及 SH2 结构域结合来抑制 Janus 酪氨酸激酶。”基因与细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasukawa H, et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18, 5. 1309-1320 (1999)
Yasukawa H 等人:“JAK 结合蛋白 JAB 通过与激活环中的结合抑制 Janus 酪氨酸激酶活性。”EMBO J.. 18, 5. 1309-1320 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yokouchi M, et al.: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis"Oncogene. 18・3. 759-767 (1999)
Yokouchi M 等人:“APS 是一种含有 PH 和 SH2 结构域的接头蛋白,与 PDGF 受体和 c-Cbl 相关,并抑制 PDGF 诱导的有丝分裂”Oncogene 18·3 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanimura S,et al.: "MDM2 interacts with MDMX through their RING finger domains." FEBS Lett.in press. (1999)
Tanimura S 等人:“MDM2 通过其无名指结构域与 MDMX 相互作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Misawa H,et al.: "Cloning and characterization of a novel class II phsophoinositide 3-kinase containing C2 domain." Biochem.Biophys.Res.Commun.244,2. 531-539 (1998)
Misawa H 等人:“含有 C2 结构域的新型 II 类磷酸肌醇 3-激酶的克隆和表征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Immune systems involved in the resolution of inflammation and tissue repair
-
批准号:17H06175
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$131.71万
-
财政年份:2017
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Identification of Cellular Signaling Mechanism that regulates inflammation and tissue repairing
-
批准号:25221305
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$122.8万
-
财政年份:2013
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Systemic Biology of T cell differentiation
-
批准号:25670234
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Systembiology of T-cell differentiation
-
批准号:23659242
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Regulatory Mechanisms of the Balance between Inflammation andAnti-inflammation by Cutokines
-
批准号:22249009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.2万
-
财政年份:2010
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Molecular Mechanism of Regulation of the Cytokine Signal and Immunity
-
批准号:18109005
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$68.64万
-
财政年份:2006
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Abnormal differentiation of tumor cells and tyrosine kinase regulation
-
批准号:17014069
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$38.34万
-
财政年份:2005
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Mechanism of Regulation of Tyrosine Kinase Signaling
-
批准号:12219216
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$109.76万
-
财政年份:2000
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Growth and differentiation signals of the erythropoietin receptor
-
批准号:09470036
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:1997
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Physiological Function and Signal Transduction Mechanism of the STAT5-target genes
-
批准号:09044349
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.06万
-
财政年份:1997
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Growth and Differentiation through the Cytokine Receptors
-
批准号:07044284
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Structure and Signal Transduction of the Erythropoietin Receptor
-
批准号:05680618
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1993
-
负责人:YOSHIMURA Akihiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
-
批准号:2026JJ82274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:侯凯
-
依托单位:
SIRT6通过去乙酰化修饰调控JAK2/STAT1信号通路介导细胞焦亡途径促进脊髓损伤进展的分子机制研究
-
批准号:2026JJ81836
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈朝晖
-
依托单位:
黄芪多糖调控JAK2/STAT3信号通路抵抗PD-L1介导的卵巢癌细胞免疫逃逸研究
-
批准号:JCZRLH202600817
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
益气活血方调控雪旺细胞外泌体/JAK2/STAT3通路介导巨噬细胞极化改善糖尿病足溃疡的作用机制研究
-
批准号:2026JJ80487
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:于洪海
-
依托单位:
NUP155-JAK2/STAT3-CD36轴协同调控线粒体凋亡与铁死亡逆转MSS型结直肠癌免疫耐受的机制研究
-
批准号:JCZRLH202601043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
乌司他丁靶向抑制HDAC1通过SOCS1/JAK2/STAT3 轴调控小胶质细胞极化来减轻局灶性脑缺血再灌注损伤的机制研究
-
批准号:2026JJ81821
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈晓曦
-
依托单位:
铜砭刮痧调控JAK1/STAT5通路减轻慢性湿疹(血虚风燥型)炎症反应的机制研究
-
批准号:2026JJ81458
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:韩倩楠
-
依托单位:
基于JAK-STAT通路调控的铁死亡探讨“补气化痰解郁” 针药合用对乳腺癌并病抑郁的作用机制
-
批准号:JCZRLH202600823
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
神经干细胞通过调控IRF7-JAK-STAT3信号通路抑制NETs形成促进糖尿病创面愈合的机制研究
-
批准号:JCZRQNB202600528
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
川芎囊泡靶向EGFR/POLR2E介导JAK2/STAT3通路抑制神经炎症干预缺血性脑卒中的分子机制
-
批准号:JCZRLH202601794
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: